Active Advisory / SVA-REG-32

Long-Shelf-Life Recall Tracking

A long date on the pack gives a recalled lot more time to remain in downstream inventory.

Michael BaoSource event 9 October 2026; FDA posting 16 OctoberWeb edition 2026-10-23

Krasnyi Oktyabr Inc. announced a recall of Starfish Seafood Premium Cold Smoked Norwegian Salmon Sliced, 227g/8oz, because of potential Listeria monocytogenes contamination. The company announcement is dated 9 October 2026; FDA posted it on 16 October.[1]

Lot
D080-148
Best before
27 November 2027
Storage method
Frozen

Use the identifiers in the notice

The notice gives UPC 4751048940099, vacuum-sealed packaging and Latvia as country of origin. It lists distribution in New York, Florida, Georgia, New Jersey, Pennsylvania and Ohio. The company says New York State sampling identified the potential contamination and that no illnesses had been reported in connection with this product at the announcement date.[1]

FDA hosts the company's announcement as a public service. That posting is not an independent FDA determination of how contamination occurred. Similarly named products and separate notices need their own lot review.

Trace the inventory that can still be held

Long-life frozen stock can remain downstream after the first recall message. For a comparable distribution system, a useful follow-up is to reconcile the named lot with quantities still held, transferred or disposed of by each recipient.

A notification record answers who was contacted. A stock reconciliation can show which quantities still need a decision. The long date makes that follow-up worth keeping open until the identified inventory is accounted for; it does not show that this particular recall remains incomplete.

Evidence & reading

Sources and scope

  1. Krasnyi Oktyabr Inc. Company recall announcement dated 9 October 2026, posted by FDA on 16 October 2026. Starfish Seafood Premium Cold Smoked Norwegian Salmon Sliced, 227g/8oz. Read source →

Company announcement and FDA posting dates are separate. Analysis concerns lot-level inventory follow-up; it does not infer a contamination source, a current illness count or incomplete recall performance.